Research on ovarian cancer described by scientists at Jikei University

Fresh data on ovarian cancer are presented in the report "Increased synthesis of indoleamine-2,3-dioxygenase protein is positively associated with impaired survival in patients with serous-type, but not with other types of, ovarian cancer. We previously reported that indoleamine-2,3-dioxygenase (IDO) is associated with paclitaxel resistance and that IDO serves as a marker of poor prognosis in ovarian serous adenocarcinomas (SA). In this study, to explore the role of IDO in the development of various histological types of ovarian cancer, we further examined IDO expression not only in SA but also in other types of ovarian cancers," scientists writing in the journal Oncology Reports...

Want to see the full article?

• Purchase this article for only $3.00